CAS: 8075-98-7; (3As,6S,6Ar)-3-((1H-Indol-3-yl)Methyl)-3,3A,6-Trihydroxytetrahydrofuro[3,2-B]Furan-2(3H)-One

该化合物是一种化学化合物,来自亚甲二醇酸(维他明C)和某些非甲醚衍生物的相互作用,特别是在受难蔬菜中发现的衍生物,被归类为植物化学,以其潜在的健康利益而著称,包括抗氧化特性和癌症预防中可能发挥的作用;Ascorbigen的典型特征是,它能够调节生物途径,特别是与解毒和细胞信号有关的途径;该化合物在各种条件下可溶于有机溶剂和展品的稳定,尽管其活动可能受到诸如pH和温度等因素的影响;对可甲二醇的研究表明其对基因表达及其与各种酶的相互作用的潜在影响,使其成为营养生物化学和药理学的一个主题;然而,还需要进一步研究,以充分阐明其行动和治疗潜力的机制.

结构式图片

MSDS等安全信息

    合成工艺路线路线简述

      海关参考信息

      专利信息


      专利号:US-2002142422-A1
      优先权日:1999-12-16
      标 题 :Moss genes from physcomitrella patens encoding proteins involved in the synthesis of amino acids, vitamins, cofactors, nucleotides and nucleosides
      发明人:LERCHL JENS; RENZ ANDREAS; EHRHARDT THOMAS; REINDL ANDREAS; CIRPUS PETRA; BISCHOFF FRIEDRICH; FRANK MARKUS; FREUND ANNETTE; DUWENIG ELKE; SCHMIDT RALF-MICHAEL; RESKI RALF
      摘要:Isolated nucleic acid molecules, designated MP protein nucleic acid molecules, which encode novel MP proteins from e.g. Phycomitrella patens are described. The invention also provides antisense nucleic acid molecules, recombinant expression vectors containing MP protein nucleic acid molecules, and host cells into which the expression vectors have been introduced. The invention still further provides isolated MP proteins, mutated MP proteins, fusion proteins, antigenic peptides and methods for the improvement of production of a desired compound from transformed cells, organisms or plants based on genetic engineering of MP protein genes in these organisms.

      专利号:WO-0007607-A1
      优先权日:1998-08-04
      标 题:Nutrient and therapeutic compositions for the treatment of cancer
      权利人:KOSBAB JOHN V
      摘要:This invention relates to nutrient and therapeutic compositions for the treatment of cancer symptoms and conditions. Compositions of this invention contain a mixture of antioxidants, components that promote collagen maintenance and synthesis, components that regulate blood lipids, glucose and/or insulin, and lower homocysteine levels. Compositions also provide supplementation for nutrient (vitamin, mineral and cofactor) deficiencies to restore and maintain normal biochemical function. Cancer formulations, particularly those adapted for treatment of female cancers, can be combined with components that provide benefit in osteoporosis.

      专利号:US-2016271177-A1
      优先权日:2015-03-18
      标 题:Process for bio synthesis of nano arsenic trioxide and its use in treatment of diseases including cancer

      专利号:EP-2897906-A1
      优先权日:2012-09-20
      标 题:Process for bio synthesis of nano arsenic trioxide and its use in treatment of diseases including cancers

      专利号:EP-2897906-B1
      优先权日:2012-09-20
      标题 :Process for bio synthesis of nano arsenic trioxide and its use in treatment of diseases including cancers
      发明人:BENDALE YOGESH NARAYAN; BENDALE VINEETA YOGESH
      权利人:BENDALE YOGESH NARAYAN; BENDALE VINEETA YOGESH

      专利号:WO-2014045083-A1
      优先权日:2012-09-20
      标题:Process for bio synthesis of nano arsenic trioxide and its use in treatment of diseases including cancers

      供应商参考报价(招募中)

      品牌试剂参考报价(招募中)

      📌 第三方产品分析报告

      ✅ COA系统入驻 | 共享模式

      合成参考文献


      摘要:Kátay G, Tyihák E, Kátay E. Effect of ascorbigen and 1'-methylascorbigen on disease resistance of bean plants to Uromyces phaseoli. Nat Prod Commun. 2011 May;6(5):611–5.
      参考文献:10.1002/mrc.4890
      摘要:Sychrovský V, Šaman D, Fiala R, Humpa O, Sýkora J, Kessler P, Blechta V, Dobrev P, Schraml J. Ascorbigen A-NMR identification. Magn Reson Chem. 2019 Dec;57(12):1084–96. doi: 10.1002/mrc.4890.
      参考文献:10.1016/0165-7992(94)90047-7
      摘要:Musk SRR, Preobrazhenskaya MN, Belitsky GA, Korolev AM, Lytcheva TA, Khitrovo IA, Johnson IT. The clastogenic and mutagenic effects of ascorbigen and 1′-methylascorbigen. Mutation Research Letters. 1994 Jan;323(1-2):69–74. doi: 10.1016/0165-7992(94)90047-7.
      摘要:KUTACEK M. [Ascorbigen from the plants of Brassicaceae family]. Postepy Biochem. 1961;7():223–42.
      📝 需求与反馈
      尽可能描述清楚需求与问题信息
      ×

      通知